GERGEN MARK J (President and CBO) received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/2/2023ACC: 0001209191-23-014898
DirectorOfficer· President and CBO
Since Jul 2020
+633.65K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
633.65K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+269.59K
Price / share
—
Trade value
—
% of position
81.2%
3/1/2023
332.02K→601.61K
Total
Net shares
+269.59K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2023 | A · Award | +269.59K | — | — | 81.2% | 332.02K | 601.61K |
| Total | +269.59K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
364.06K shares
Shares
+364.06K
Strike price
5.35
Held after
364.06K
Exercisable
—
3/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock364.06K shares | 3/1/2023 | A · Award | +364.06K | 5.35 | — | 364.06K |